478 related articles for article (PubMed ID: 27581040)
1. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.
Sternak M; Khomich TI; Jakubowski A; Szafarz M; Szczepański W; Białas M; Stojak M; Szymura-Oleksiak J; Chłopicki S
Pharmacol Rep; 2010; 62(3):483-93. PubMed ID: 20631412
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
4. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.
Chłopicki S; Kurdziel M; Sternak M; Szafarz M; Szymura-Oleksiak J; Kamiński K; Żołądź JA
Pharmacol Rep; 2012; 64(2):369-76. PubMed ID: 22661188
[TBL] [Abstract][Full Text] [Related]
5. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
[TBL] [Abstract][Full Text] [Related]
6. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
Kannt A; Pfenninger A; Teichert L; Tönjes A; Dietrich A; Schön MR; Klöting N; Blüher M
Diabetologia; 2015 Apr; 58(4):799-808. PubMed ID: 25596852
[TBL] [Abstract][Full Text] [Related]
7. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis.
Mateuszuk Ł; Khomich TI; Słomińska E; Gajda M; Wójcik L; Łomnicka M; Gwóźdź P; Chłopicki S
Pharmacol Rep; 2009; 61(1):76-85. PubMed ID: 19307695
[TBL] [Abstract][Full Text] [Related]
8. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
[TBL] [Abstract][Full Text] [Related]
10. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
11. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
14. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
16. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Leong ZP; Hikasa Y
Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats.
Kanno S; Wu YJ; Lee PC; Billiar TR; Ho C
Circulation; 2001 Aug; 104(8):945-50. PubMed ID: 11514384
[TBL] [Abstract][Full Text] [Related]
18. Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats.
Yin J; You S; Li N; Jiao S; Hu H; Xue M; Wang Y; Cheng W; Liu J; Xu M; Yan S; Li X
Respir Res; 2016 Aug; 17(1):99. PubMed ID: 27491388
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 promotes the development of pulmonary arterial hypertension in rats.
Sadamura-Takenaka Y; Ito T; Noma S; Oyama Y; Yamada S; Kawahara K; Inoue H; Maruyama I
PLoS One; 2014; 9(7):e102482. PubMed ID: 25032709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]